Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,736.40
(
1.03%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
111.34
(
0.90%
)
Bitcoin
76,602.73
(
0.36%
)
News Focus
News Focus
Post# of 447691
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 142
Posts 23910
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Re: hamkypamky post# 314001

Tuesday, 12/08/2020 8:37:44 PM

Tuesday, December 08, 2020 8:37:44 PM

Post# of 447691
Ham. There’s an ICER report on cost effectiveness ( which cohort etc ) for Vascepa
Are U familiar with it ?
Vascepa is very cost effective for prior event ( ie you have stents or had a bypass ) CAD patients .
Show me the data that it’s cost effective for a patient simply with high TG’s that is not diagnosed CAD
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News